Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women

Diabetologia

Volumn 49, Issue 1, 2006, Pages 56-65

  Juutilainen, A ^a   Lehto, S ^a   Ronnemaa T ^b   Pyorala K ^a   Laakso, M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Cardiovascular disease; Metabolic syndrome; Proteinuria

Indexed keywords

PROTEIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN URINE LEVEL; PROTEINURIA; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FINLAND; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROTEINURIA; REPRODUCIBILITY OF RESULTS; WORLD HEALTH ORGANIZATION;

EID: 31444441462     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-0050-1     Document Type: Article

References (50)

1. Schmitz A, Vaeth M (1988) Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5:126-134
2. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G (1992) Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41:736-741
3. Mogensen CE, Damsgaard EM, Froland A, Nielsen S, de Fine Olivarius N, Schmitz A (1992) Microalbuminuria in non-insulin-dependent diabetes. Clin Nephrol 38(Suppl 1):S28-S39
4. Beatty OL, Ritchie CM, Bell PM, Hadden DR, Kennedy L, Atkinson AB (1995) Microalbuminuria as identified by a spot morning urine specimen in non-insulin-treated diabetes: an eight-year follow-up study. Diabet Med 12:261-266
5. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1996) Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033-2039
6. Dinneen SF, Gerstein HC (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157:1413-1418
7. Valmadrid CT, Klein R, Moss SE, Klein BE (2000) The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160:1093-1100
8. Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 2:530-533
9. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE (1990) Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297-300
10. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M (1995) Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 91:831-837
11. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS (1999) Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19:1992-1997
12. Hillege HL, Fidler V, Diercks GF (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777-1782
13. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
14. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442-443
15. Jager A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD (1998) Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 41:694-700
16. Bigazzi R, Bianchi S, Campese VM, Baldari G (1992) Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 61:94-97
17. Foyle WJ, Carstensen E, Fernandez MC, Yudkin JS (1995) Longitudinal study of associations of microalbuminuria with the insulin resistance syndrome and sodium-lithium counter-transport in nondiabetic subjects. Arterioscler Thromb Vasc Biol 15:1330-1337
18. Toft I, Bonaa KH, Eikrem J, Bendiksen AL, Iversen H, Jenssen T (2002) Microalbuminuria in hypertension is not a determinant of insulin resistance. Kidney Int 61:1445-1452
19. Cirillo M, Senigalliesi L, Laurenzi M et al. (1998) Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study. Arch Intern Med 158:1933-1939
20. Abuaisha B, Kumar S, Malik R, Boulton AJ (1998) Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 39:93-99
21. Cubeddu LX, Hoffmann IS, Aponte LM et al. (2003) Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. Am J Hypertens 16:343-349
22. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I (1988) Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 11:449-463
23. World Health Organization (1983) Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). World Health Organization, Geneva
24. Walker AE, Robins M, Weinfeld FD (1981) The National Survey of Stroke. Clinical findings. Stroke 12:I13-I44
25. Van Kley H, Hale SM (1977) Assay for protein by dye binding. Anal Biochem 81:485-487
26. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyörälä K (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164:1066-1076
27. Isomaa B, Almgren P, Tuomi T et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689
28. Lakka HM, Laaksonen DE, Lakka TA et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716
29. Bonora E, Kiechl S, Willeit J et al. (2003) Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 27:1283-1289
30. Bonora E, Targher G, Formentini G et al. (2004) The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med 21:52-58
31. Bruno G, Merletti F, Biggeri A et al. (2004) Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27:2689-2694
32. McNeill AM, Rosamond WD, Girman CJ et al. (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28:385-390
33. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP (2004) National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110:1251-1257
34. Malik S, Wong ND, Franklin SS et al. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110:1245-1250
35. Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552-557
36. Agewall S, Fagerberg B, Attvall S (1995) Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group. J Intern Med 237:195-203
37. Bianchi S, Bigazzi R, Quinones Galvan A et al. (1995) Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension 26:789-795
38. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM (1998) Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabetes 47:793-800
39. El-Atat FA, Stas SN, McFarlane SI, Sowers JR (2004) The relationships between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 15:2816-2827
40. Cerasola G, Cottone S, Mule G et al. (1996) Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 14:915-920
41. Redon J, Liao Y, Lozano JV, Miralles A, Baldo E, Cooper RS (1994) Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens 7:801-807
42. Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG (1992) Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 93:71-81
43. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK (1990) Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10:727-731
44. Tapp RJ, Shaw JE, Zimmet PZ et al. (2004) Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis 44:792-798
45. Yudkin JS (1992) Microalbuminuria: a genetic link between diabetes and cardiovascular disease? Ann Med 24:517-522
46. Ginsberg JM, Chang BS, Matarese RA, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309:1543-1546
47. Ralston SH, Caine N, Richards I, O'Reilly D, Sturrock RD, Capell HA (1988) Screening for proteinuria in a rheumatology clinic: comparison of dipstick testing, 24 hour urine quantitative protein, and protein/creatinine ratio in random urine samples. Ann Rheum Dis 47:759-763
48. Agrawal B, Berger A, Wolf K, Luft FC (1996) Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 14:223-228
49. Mogensen CE, Schmitz O (1988) The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North Am 72:1465-1492
50. Atkins RC, Briganti EM, Zimmet PZ, Chadban SJ (2003) Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant 18:2170-2174